Hematology
Sara Hurvitz, MD
Senior Vice President and Director, Clinical Research Division, Fred Hutch; Professor, Division of Hematology and Oncology, University of Washington
Dr. Hurvitz is an international expert in breast oncology and a leader in clinical and laboratory-based oncology research. She oversees clinical research programs in solid tumor research, stem cell transplantation and cell therapy, hematologic cancers, and nonmalignant hematology at Fred Hutch. Her clinical focus includes neoadjuvant treatments and novel targeted therapies against HER2, ER-positive, and triple-negative breast cancer.
25+
Years in Practice
Credentials
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Education & Training
- Medical School: Keck School of Medicine, USC (MD, 1999)
- Residency: UCLA (Internal Medicine, 1999-2002)
- Fellowship: UCLA (Hematology/Oncology, 2002-2006)
Peer Recognition
- Castle Connolly — Top Doctor
2017-2026 (10 years)
- Healthgrades — Healthgrades Honor Roll
- Healthgrades — American Society of Clinical Oncology Merit Award, June 2006
- Healthgrades — American Society of Clinical Oncology Young Investigator Award, 6/3/07
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Santa Monica UCLA Medical Center and Orthopaedic Hospital
- Eisenhower Medical Center
- Island Hospital
- Division of Medical Genetics, University of Washington
- Ronald Reagan UCLA Medical Center
Experience
25+ years in practice